Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement. [electronic resource] by
- Gregory, K J
- Herman, E J
- Ramsey, A J
- Hammond, A S
- Byun, N E
- Stauffer, S R
- Manka, J T
- Jadhav, S
- Bridges, T M
- Weaver, C D
- Niswender, C M
- Steckler, T
- Drinkenburg, W H
- Ahnaou, A
- Lavreysen, H
- Macdonald, G J
- Bartolomé, J M
- Mackie, C
- Hrupka, B J
- Caron, M G
- Daigle, T L
- Lindsley, C W
- Conn, P J
- Jones, C K
Producer: 20131223
In:
The Journal of pharmacology and experimental therapeutics vol. 347
Availability: No items available.
|